McCluggage, W. G., Singh, N. & Gilks, C. B. Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). Histopathology 80, 762–778 (2022).
Shih, I. M., Wang, Y. & Wang, T. L. The origin of ovarian cancer species and precancerous landscape. Am. J. Pathol. 191, 26–39 (2021).
Article CAS PubMed PubMed Central Google Scholar
Cheasley, D. et al. The molecular origin and taxonomy of mucinous ovarian carcinoma. Nat. Commun. 10, 3935 (2019).
Article PubMed PubMed Central Google Scholar
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
Webb, P. M., Green, A. C. & Jordan, S. J. Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future. Cancer Causes Control. 28, 365–370 (2017).
Cabasag, C. J. et al. The influence of birth cohort and calendar period on global trends in ovarian cancer incidence. Int. J. Cancer 146, 749–758 (2020).
Article CAS PubMed Google Scholar
Ervik, M., Lam, F., Laversanne, M., Ferlay, J. & Bray, F. Global Cancer Observatory: Cancer Over Time https://gco.iarc.fr/overtime (2021).
GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400, 563–591 (2022).
Long Roche, K. C., Abu-Rustum, N. R., Nourmoussavi, M. & Zivanovic, O. Risk-reducing salpingectomy: let us be opportunistic. Cancer 123, 1714–1720 (2017).
Article CAS PubMed Google Scholar
Nitschke, A. S., do Valle, H. A., Dawson, L., Kwon, J. S. & Hanley, G. E. Long-term non-cancer risks in people with BRCA mutations following risk-reducing bilateral salpingo-oophorectomy and the role of hormone replacement therapy: a review. Cancers 15, 711 (2023).
Article CAS PubMed PubMed Central Google Scholar
Yoon, S. H., Kim, S. N., Shim, S. H., Kang, S. B. & Lee, S. J. Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis. Eur. J. Cancer 55, 38–46 (2016).
Chen, Y., Du, H., Bao, L. & Liu, W. Opportunistic salpingectomy at benign gynecological surgery for reducing ovarian cancer risk: a 10-year single centre experience from China and a literature review. J. Cancer 9, 141–147 (2018).
Article PubMed PubMed Central Google Scholar
Hanley, G. E. et al. Outcomes from opportunistic salpingectomy for ovarian cancer prevention. JAMA Netw. Open 5, e2147343 (2022).
Article PubMed PubMed Central Google Scholar
Darelius, A., Kristjansdottir, B., Dahm-Kahler, P. & Strandell, A. Risk of epithelial ovarian cancer type I and II after hysterectomy, salpingectomy and tubal ligation — a nationwide case-control study. Int. J. Cancer 149, 1544–1552 (2021).
Article CAS PubMed Google Scholar
Duus, A. H., Zheng, G., Baandrup, L., Faber, M. T. & Kjaer, S. K. Risk of ovarian cancer after salpingectomy and tubal ligation: prospects on histology and time since the procedure. Gynecol. Oncol. 177, 125–131 (2023).
Article CAS PubMed Google Scholar
Leblanc, E. et al. Prophylactic radical fimbriectomy with delayed oophorectomy in women with a high risk of developing an ovarian carcinoma: results of a prospective national pilot study. Cancers 15, 1141 (2023).
Article CAS PubMed PubMed Central Google Scholar
Webb, P. M. & Jordan, S. J. Epidemiology of epithelial ovarian cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 41, 3–14 (2017).
Peres, L. C. et al. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int. J. Epidemiol. 47, 460–472 (2018).
Jervis, S. et al. Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants. J. Med. Genet. 51, 108–113 (2014).
Article CAS PubMed Google Scholar
Flaum, N., Crosbie, E. J., Edmondson, R. J., Smith, M. J. & Evans, D. G. Epithelial ovarian cancer risk: a review of the current genetic landscape. Clin. Genet. 97, 54–63 (2020).
Article CAS PubMed Google Scholar
Norquist, B. M. et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2, 482–490 (2016).
Article PubMed PubMed Central Google Scholar
Phelan, C. M. et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat. Genet. 49, 680–691 (2017).
Article CAS PubMed PubMed Central Google Scholar
Setiawan, V. W. et al. Type I and II endometrial cancers: have they different risk factors? J. Clin. Oncol. 31, 2607–2618 (2013).
Article PubMed PubMed Central Google Scholar
Gong, T. T., Wu, Q. J., Vogtmann, E., Lin, B. & Wang, Y. L. Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies. Int. J. Cancer 132, 2894–2900 (2013).
Article CAS PubMed Google Scholar
Wentzensen, N. et al. Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium. J. Clin. Oncol. 34, 2888–2898 (2016).
Article CAS PubMed PubMed Central Google Scholar
Yarmolinsky, J. et al. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: a Mendelian randomization analysis. PLoS Med. 16, e1002893 (2019).
Article PubMed PubMed Central Google Scholar
Yang, H. et al. Age at menarche and epithelial ovarian cancer risk: a meta-analysis and Mendelian randomization study. Cancer Med. 8, 4012–4022 (2019).
Article CAS PubMed PubMed Central Google Scholar
Fu, Z. et al. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. J. Natl Cancer Inst. 115, 539–551 (2023).
Article PubMed PubMed Central Google Scholar
Husby, A., Wohlfahrt, J. & Melbye, M. Pregnancy duration and ovarian cancer risk: a 50-year nationwide cohort study. Int. J. Cancer 151, 1717–1725 (2022).
Article CAS PubMed PubMed Central Google Scholar
Wu, Y., Sun, W., Xin, X., Wang, W. & Zhang, D. Age at last birth and risk of developing epithelial ovarian cancer: a meta-analysis. Biosci. Rep. 39, BSR20182035 (2019).
Article CAS PubMed PubMed Central Google Scholar
Lee, A. W. et al. Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies. J. Natl Cancer Inst. 113, 301–308 (2021).
World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: A Global Perspective (World Cancer Research Fund International, 2018).
Gaitskell, K. et al. Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study. Int. J. Cancer 142, 281–289 (2018).
Article CAS PubMed Google Scholar
Babic, A. et al. Association between breastfeeding and ovarian cancer risk. JAMA Oncol. 6, e200421 (2020).
Article PubMed PubMed Central Google Scholar
Kotsopoulos, J. et al. Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation. Gynecol. Oncol. 159, 820–826 (2020).
Article CAS PubMed Google Scholar
Barcroft, J. F. et al. Fertility treatment and cancers-the eternal conundrum: a systematic review and meta-analysis. Hum. Reprod. 36, 1093–1107 (2021).
Lerner-Geva, L. et al. Subfertility, use of fertility treatments and BRCA mutation status and the risk of ovarian cancer. Arch. Gynecol. Obstet. 306, 209–217 (2022).
Article CAS PubMed Google Scholar
Dixon-Suen, S. C. et al. The association between hysterectomy and ovarian cancer risk: a population-based record-linkage study. J. Natl Cancer Inst. 111, 1097–1103 (2019).
Article PubMed PubMed Central Google Scholar
Khoja, L. et al. Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. Gynecol. Oncol. 164, 195–201 (2022).
Comments (0)